Other grades of this product :
| Product Name: | BTO-1 | | Synonyms: | BTO-1;5-Cyano-7-nitro-2-benzothiazolecarboxamide-3-oxide;Polo-like Kinase Inhibitor II, BTO-1;Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem | | CAS: | 40647-02-7 | | MF: | C9H4N4O4S | | MW: | 264.22 | | EINECS: | | Product Categories: | | Mol File: | 40647-02-7.mol |
| BTO-1 Chemical Properties |
| storage temp. | 2-8°C | | solubility | H2O: <2ML/mL | | form | solid | | color | tan |
| BTO-1 Usage And Synthesis |
| Uses | BTO-1 is a benzothiazolo-N-oxide Plk1 inhibitor. | | General Description | A cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays (IC50 = 8.0 μM) and suppress the phosphorylation of cellular Plk1 substrate Cdc25C in rat kangaroo kidney-derived PTK cells (75% inhibition at 6.3 μM). BTO-1 treatment of cultured cells results in mitosis defects consistent with loss-of-Plk1 phenotypes seen in Plk1 RNAi-treated U20S cells, including the appearance of monopolar spindles and the reduction of γ-tubulin at the centrosomes. Plk1 inhibition by BTO-1 in HeLa cells results in a blockage of Rho and Rho-GEF recruitment, which is essential for the assembly of a functional contractile ring. | | Biochem/physiol Actions | BTO-1 is a polo-like kinase (Plk) inhibitor. |
| BTO-1 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye